儿科

订阅

MedSci主页 / 所有栏目 / 儿科

A型血友病治疗前沿：SubQ-8（一种新型重组FVIII）的新近进展

2019-07-08 Allan MedSci原创

SubQ-8A型血友病重组FVIII
关注

Octapharma公司近日在第27届国际血栓形成和止血学会（ISTH）的科学研讨会上介绍了SubQ-8临床开发计划和临床前数据的最新情况。SubQ-8将人细胞系衍生的重组FVIII（simoctocog alfa）与人细胞系中产生的重组VWF片段二聚体相结合，以促进皮下摄入FVIII。

Octapharma公司近日在第27届国际血栓形成和止血学会（ISTH）的科学研讨会上介绍了SubQ-8临床开发计划和临床前数据的最新情况。SubQ-8将人细胞系衍生的重组FVIII（simoctocog alfa）与人细胞系中产生的重组VWF片段二聚体相结合，以促进皮下摄入FVIII。Octapharma董事会成员Olaf Walter说：“Octapharma致力于改善凝血功能障碍患者的生活质量，我们很自豪能够开发出具有这种潜力的产品，以满足A型血友病患者的主要需求”。

A型血友病是由于缺乏第8凝血因子（即FVIII）所引起的，是临床上最常见的血友病，约占血友病人数的80%-85%，在某些血友病高发地区甚至更高。 


原始出处：

http://www.firstwordpharma.com/node/1651657#axzz5syvQI0kQ

本文系梅斯医学（MedSci）原创编译整理，转载需授权!

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1678148, encodeId=1b1a16e8148c1, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Apr 29 06:35:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916125, encodeId=9a291916125b4, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Sun Jan 12 16:35:00 CST 2020, time=2020-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715780, encodeId=c69e1e15780e2, content=<a href='/topic/show?id=b9bbe73853' target=_blank style='color:#2F92EE;'>#FVIII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7738, encryptionId=b9bbe73853, topicName=FVIII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=487e32047562, createdName=wjcjjian, createdTime=Wed Feb 12 07:35:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264136, encodeId=d06f1264136bc, content=<a href='/topic/show?id=ffb03111a1' target=_blank style='color:#2F92EE;'>#A型血友病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3111, encryptionId=ffb03111a1, topicName=A型血友病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Jul 10 08:35:00 CST 2019, time=2019-07-10, status=1, ipAttribution=)]
    2020-04-29 仁者大医

    #A型血#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1678148, encodeId=1b1a16e8148c1, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Apr 29 06:35:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916125, encodeId=9a291916125b4, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Sun Jan 12 16:35:00 CST 2020, time=2020-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715780, encodeId=c69e1e15780e2, content=<a href='/topic/show?id=b9bbe73853' target=_blank style='color:#2F92EE;'>#FVIII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7738, encryptionId=b9bbe73853, topicName=FVIII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=487e32047562, createdName=wjcjjian, createdTime=Wed Feb 12 07:35:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264136, encodeId=d06f1264136bc, content=<a href='/topic/show?id=ffb03111a1' target=_blank style='color:#2F92EE;'>#A型血友病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3111, encryptionId=ffb03111a1, topicName=A型血友病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Jul 10 08:35:00 CST 2019, time=2019-07-10, status=1, ipAttribution=)]
    2020-01-12 juliusluan78

    #III#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1678148, encodeId=1b1a16e8148c1, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Apr 29 06:35:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916125, encodeId=9a291916125b4, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Sun Jan 12 16:35:00 CST 2020, time=2020-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715780, encodeId=c69e1e15780e2, content=<a href='/topic/show?id=b9bbe73853' target=_blank style='color:#2F92EE;'>#FVIII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7738, encryptionId=b9bbe73853, topicName=FVIII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=487e32047562, createdName=wjcjjian, createdTime=Wed Feb 12 07:35:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264136, encodeId=d06f1264136bc, content=<a href='/topic/show?id=ffb03111a1' target=_blank style='color:#2F92EE;'>#A型血友病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3111, encryptionId=ffb03111a1, topicName=A型血友病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Jul 10 08:35:00 CST 2019, time=2019-07-10, status=1, ipAttribution=)]
    2020-02-12 wjcjjian

    #FVIII#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1678148, encodeId=1b1a16e8148c1, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Apr 29 06:35:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916125, encodeId=9a291916125b4, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Sun Jan 12 16:35:00 CST 2020, time=2020-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715780, encodeId=c69e1e15780e2, content=<a href='/topic/show?id=b9bbe73853' target=_blank style='color:#2F92EE;'>#FVIII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7738, encryptionId=b9bbe73853, topicName=FVIII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=487e32047562, createdName=wjcjjian, createdTime=Wed Feb 12 07:35:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264136, encodeId=d06f1264136bc, content=<a href='/topic/show?id=ffb03111a1' target=_blank style='color:#2F92EE;'>#A型血友病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3111, encryptionId=ffb03111a1, topicName=A型血友病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Jul 10 08:35:00 CST 2019, time=2019-07-10, status=1, ipAttribution=)]
    2019-07-10 changfy

    #A型血友病#

    0